David Blumenthal, MD
- Specialty: Rheumatology
-
Primary Location: 11100 Euclid Ave (0 mi.)
Other Locations - Languages Spoken: English
Office Locations
DO Mather 1500 (0 mi.)
11100 Euclid Ave
Mather Ste 1500
Cleveland, OH 44106
216-844-2289
UH Minoff Health Center at Chagrin Highlands (7 mi.)
3909 Orange Pl
Ste 3200
Beachwood, OH 44122
216-844-8500
Strongsville Medical Center (19 mi.)
18181 Pearl Rd
Ste B204
Strongsville, OH 44136
440-816-4925
Biography: David Blumenthal, MD
Certifications & Memberships
- Internal Medicine - American Board of Internal Medicine
Education
Research Fellowship | Rheumatology
Rheumatology - Washington University School Of Medicine In St Louis (1992 - 1993)
Fellowship | Rheumatology
Rheumatology - Barnes-Jewish Hospital (1989 - 1993)
Residency | Internal Medicine
Internal Medicine - Barnes-Jewish Hospital (1983 - 1986)
Medical Education
Washington University School Of Medicine In St Louis (1983)
Undergraduate
Brown University (1979)
About
Dr. David Blumenthal graduated from Washington University School of Medicine in St. Louis in 1983 and completed his internal medicine residency and rheumatology fellowship at Barnes-Jewish Hospital in St. Louis. Since completing his training, he has been a faculty rheumatologist at Barnes-Jewish Hospital and the VA Medical Center in St. Louis, Cleveland Clinic, MetroHealth Medical Center, Louis Stokes Cleveland VA Medical Center and University Hospitals Cleveland Medical Center.
He is currently Interim Chief of the Division of Rheumatology at University Hospitals Cleveland Medical Center and Director of the University Hospitals Cleveland Medical Center/Cleveland VA Medical Center Fellowship in Rheumatology.
His clinical interests are the diagnosis and treatment of pulmonary inflammation and fibrosis in systemic autoimmune diseases such as rheumatoid arthritis, scleroderma, autoimmune myositis, systemic lupus and vasculitis.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, David Blumenthal did not disclose any Outside Relationships with Industry.